C12N2760/18722 - CPC Classification Index

#1

20260069674

2026-03-12

PIV5-BASED COVID-19 VACCINE

#2

20250319176

2025-10-16

PIV5-BASED COVID-19 VACCINE

#3

20250223572

2025-07-10

PARAMYXOVIRUS VIRUS-LIKE PARTICLES AS PROTEIN DELIVERY VEHICLES

#4

20240316180

2024-09-26

ATTENUATED MUMPS VACCINE AND USES THEREOF

#5

20240309053

2024-09-19

RECOMBINANT HUMAN/BOVINE PARAINFLUENZA VIRUS 3 (B/HPIV3) EXPRESSING A CHIMERIC RSV/PIV3 F PROTEIN AND USES THEREOF

#6

20240287544

2024-08-29

MODIFIED PIV5 VACCINE VECTORS: METHODS OF MAKING AND USES

#7

20230287055

2023-09-14

Recombinant human parainfluenza virus type 1 expressing a chimeric RSV/HPIV1 f protein and uses thereof

#8

20220267740

2022-08-25

Paramyxovirus virus-like particles as protein delivery vehicles

#9

20220162567

2022-05-26

PARAMYXOVIRUS VIRUS-LIKE PARTICLES AS PROTEIN DELIVERY VEHICLES

#10

20200277338

2020-09-03

Recombinant human/bovine parainfluenza virus 1 (HPIV1) expressing a chimeric RSV/HPIV1 F protein and uses thereof

#11

20190338253

2019-11-07

Paramyxovirus virus-like particles as protein delivery vehicles

#12

20180312544

2018-11-01

Recombinant human/bovine parainfluenza virus 3 (B/HPIV3) expressing a chimeric RSV/BPIV3 F protein and uses thereof

#13

20170175086

2017-06-22

Paramyxovirus virus-like particles as protein delivery vehicles

#14

20130052718

2013-02-28

Attenuated human parainfluenza virus, methods and uses thereof

#15

20130023030

2013-01-24

Recovery of recombinant human parainfluenza virus type 2 (HYPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens

#16

20110318355

2011-12-29

Mutant proteins of the F protein of PIV-5 and PIV-2

#17

20110311541

2011-12-22

Mutant proteins of the F protein of PIV-5 and PIV-2

#18

20110275146

2011-11-10

FUSION PROTEINS COMPRISING DP-178 AND OTHER VIRAL FUSION INHIBITOR PEPTIDES USEFUL FOR TREATING AIDS

#19

20110143422

2011-06-16

Recovery of recombinant human parainfluenza virus type 2 (HYPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens

#20

20100291680

2010-11-18

METHODS AND COMPOSITIONS FOR INHIBITION OF MEMBRANE FUSION-ASSOCIATED EVENTS, INCLUDING HIV TRANSMISSION

#21

20100279273

2010-11-04

NUCLEIC ACID SEQUENCES FOR THE AMPLIFICATION AND DETECTION OF RESPIRATORY VIRUSES

#22

20090035853

2009-02-05

TSG101-GAG INTERACTION AND USE THEREOF

#23

20080286848

2008-11-20

Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from CDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens

#24

20080227740

2008-09-18

Compositions and Methods for Elimination of Unwanted Cells

#25

20080226610

2008-09-18

Compositions and Methods for Elimination of Unwanted Cells

#26

20080188640

2008-08-07

Immunodeficiency recombinant poxvirus

#27

20080171027

2008-07-17

Compositions and Methods for Elimination of Unwanted Cells

#28

20080171026

2008-07-17

Compositions and methods for elimination of unwanted cells

#29

20070258997

2007-11-08

Rescue of mumps virus from CDNA

#30

20070253972

2007-11-01

Rescue of mumps virus from cDNA

#31

20070202127

2007-08-30

Nucleic acids encoding DP-178 and other viral fusion inhibitor peptides useful for treating aids

#32

20070202123

2007-08-30

Antifusogenic proteins comprising human immunodeficiency virus type 1 (HIV-1) gp41 DP-178 polypeptide variants and a macromolecular carrier

#33

20070037141

2007-02-15

Methods and compositions for inhibition of membrane fusion-associated events, including HIV transmission

#34

20060051335

2006-03-09

Compositions and methods for elimination of unwanted cells